Our Science

Overview

Aging is a growing problem for both individual quality of life and the economics of societal health. Age is the primary risk factor for the majority of the top causes of death in the United States. My laboratory uses systems and comparative genetics to identify and characterize novel mechanisms of aging. By understanding the molecular architecture that drives aging, our goal is to identify key intervention points to simultaneously delay onset of many age-associated diseases and extend healthy lifespan. We employ a formal experimental pipeline that leverages the strengths of four model systems—humans, cell culture, mice, and nematodes—to (1) generate candidate interventions or intervention targets through systems-level studies in humans, (2) screen candidate interventions for extension of lifespan or other age-related phenotypes in the nematode Caenorhabditis elegans, (3) characterize mechanisms of lifespan extension for selected candidates in C. elegans, (4) validate mechanistic models and examine tissue-specific phenotypes in mice and cell culture, (5) develop targeted interventions to slow aging or treat age-associated disease in mice, and (6) translate promising interventions to the clinic. Through application of this pipeline, we have developed a molecular focus on understanding the complex interaction between metabolism and stress response during aging. We also support this pipeline through the development of new tools for high-content aging analysis in C. elegans. The sections below highlight ongoing projects in the Sutphin Lab.

Targeting kynurenine metabolism in aging

The kynurenine pathway—the major metabolic route for ingested tryptophan—becomes dysregulated with age and is implicated as a driver of aging. We find that elevating physiological levels of the kynurenine pathway metabolite 3-hydroxyanthranilic acid (3HAA) through dietary supplementation or inhibition of 3HAA dioxygenase (HAAO) extends lifespan and metrics of late-life health in both C. elegans and mice. Understanding the mechanisms that mediate the benefits of 3HAA and developing 3HAA-based therapeutics for aging is a major focus of our research. Current projects are focused on optimizing 3HAA for lifespan extension and impact on immune function and stress resilience.

Defining the genetic architecture of multiple stress response

The goal of this work is to understand the fundamental biology of cellular response to different forms and combinations of stress. Cells are constantly subjected to intrinsic and extrinsic stresses—reactive oxygen species, protein misfolding, osmotic stress—that negatively impact cellular structure and function. In response, cells activate a range of molecular pathways to mitigate and repair damage—oxidative stress response, unfolded protein response, osmotic stress response. Several interventions that improve health, such as dietary restriction, both activate stress response pathways and promote multi-stress resistance. While individual stress response pathways are reasonably well defined, how stress responses differ when cells are challenged with multiple forms of stress simultaneously is less well understood and represents a critical knowledge gap. This gap has broad implications for medicine. Human diseases rarely involve a single form of stress—Alzheimer’s disease is characterized by neuroinflammation, increased oxidative stress, and accumulation of misfolded proteins, while cancer exhibits oxidative stress, DNA damage, and localized hypoxia. By understanding the network of molecular pathways that define cellular stress response, we aim to identify intervention points that can be targeted to activate distinct stress response profiles that improve health, combat disease, and enhance resilience. The long-term goal of this research program is to answer fundamental questions about the biology of stress response: (1) How is the molecular stress response network organized? (2) Which elements of this network are general (responsive to many types of stress) and which are specific (responsive to specific stressors)? (3) How does the cellular response to one type of stress alter an organism’s resistance to other types? (4) Are there key molecular nodes in the stress response network that can be targeted to improve health or treat specific diseases?

Technology development for high-content aging research

A major focus of our laboratory is the development of new technologies and methods to accelerate aging research. We are particularly interested in advancing tools for high-content screening in C. elegans. Recent technological advances bring us to the cusp of true high-content data collection methods for long-term tracking of individual Caenorhabditis elegans. C. elegans is a major experimental system across many disciplines ranging from the fundamentals of molecular and cellular biology to complex multicellular processes like development, aging, stress response, neurobiology, and behavior. C. elegans’ popularity reflects its many attractive experimental features—ease of maintenance, rapid reproductive and life cycles, a well-characterized genome, and the availability of a wealth of powerful molecular tools. Standard methods typically examine group-cultured animals on solid media or, more recently, individually cultured animals in microfluidic devices. The former is amenable to high-throughput applications but is usually restricted to one or a few phenotypes per group. The latter provides single-animal resolution, which is important for understanding individual variation in a process of interest and the underlying interaction between molecular drivers of that process, but is difficult to scale and involves culturing animals in liquid media, which induces distinct physiological responses relative to standard growth on solid media. There is a growing critical need for tools that allow high-throughput collection of high-content data in individual animals throughout life. The foundation for building these tools is established by recent advances in solid media-based single-worm culture systems, automated data collection for physiological phenotypes like survival and activity, and automated quantification of fluorescent biomarkers. Over the past several years we have developed a culture system and a robotic imaging platform (Nemadex) that enables automated measurement of multiple physiological characteristics—survival, activity, health—longitudinally in isolated individual C. elegans. In parallel, we have developed analytical tools for rapid, autonomous quantification of fluorescent biomarkers reporting activity in a wide range of molecular processes. In building Nemadex, we have developed a number of focused tools for single-worm culture, rapid fluorescence quantification, and tracking of bacterial colonies in the C. elegans intestine.

Cholesterol metabolism in aging and age-associated disease

Cholesterol has long been a boogeyman in human health, with good reason. Circulating cholesterol is associated with increased risk for multiple diseases of aging, particularly cardiovascular disease. However, this risk comes not from cholesterol itself, but the low-density lipoprotein (LDL) particles that transport cholesterol from liver to peripheral tissue. Most cholesterol is not in circulation but localized within our cells, where it plays vital roles in membrane structure and the production of hormones, vitamins, and bile acids. We recently discovered that cholesterol supplementation robustly and dramatically extends healthy lifespan in the roundworm C. elegans. Our objective in this project is to identify the genes and molecular processes downstream of cholesterol that mediate these benefits. Our long-term goal is to target these processes directly, capturing the benefits of cholesterol without increasing LDL. Indeed, we aim to combine our targeted approach with LDL-lowering therapies to achieve synergistic benefit in the context of healthy longevity.